Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy

Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy

Background/purpose: Distinct hepatitis relapse has been observed after discontinuing entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy in chronic hepatitis B (CHB) patients. End-of-therapy (EOT) serum cytokines were compared and used for outcome prediction. Methods: A total of 80 non-ci...

Full description

Bibliographic Details
Main Authors: Meng-Ju Lin, Tung-Hung Su, Chun-Jen Liu, Hung-Chih Yang, Chi-Ling Chen, Jyh-Ming Liou, Tai-Chung Tseng, Chen-Hua Liu, Chun-Ming Hong, Pei-Jer Chen, Jia-Horng Kao
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Journal of the Formosan Medical Association
Subjects:
Chronic hepatitis B
Nucleos(t)ide analogue
Antiviral therapy
Hepatitis flare
Cytokine
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664623000384

Internet

http://www.sciencedirect.com/science/article/pii/S0929664623000384

Similar Items